By Connor Hart
Shares of 908 Devices opened higher after the company said it expects full-year revenue to come in at the high end of its previously guided range.
The stock was trading hands at $6.28 in morning trading Tuesday, up 15%. Shares have more than doubled over the past year.
The maker of chemical-analysis devices before the bell said it expects revenue of about $56 million in 2025, marking a 17% increase from the previous year. It had previously forecast full-year revenue of $54 million to $56 million. Analysts are expecting $54.8 million, according to FactSet.
For the fourth quarter, 908 Devices expects revenue to climb about 20% year over year, to $17.2 million. The company attributed the gain to continued outperformance in the U.S., ramping international adoption of products, and sales to federal and defense customers.
"In 2025, we transformed our company into a stronger, simpler and more profitable financial model focused on frontline chemical detection," Chief Executive Kevin Knopp said.
908 Devices said it plans to report its full fourth-quarter and full-year results later this quarter, at which time it will provide its 2026 outlook.
Write to Connor Hart at connor.hart@wsj.com
(END) Dow Jones Newswires
January 20, 2026 09:53 ET (14:53 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.